[HTML][HTML] Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

IP Trougakos, E Terpos, H Alexopoulos… - Trends in molecular …, 2022 - cell.com
Vaccination is a major tool for mitigating the coronavirus disease 2019 (COVID-19)
pandemic, and mRNA vaccines are central to the ongoing vaccination campaign that is …

[HTML][HTML] Post-COVID syndrome: an insight on its pathogenesis

HC Maltezou, A Pavli, A Tsakris - Vaccines, 2021 - mdpi.com
Post-COVID syndrome is increasingly recognized as a new clinical entity in the context of
SARS-CoV-2 infection. Symptoms persisting for more than three weeks after the diagnosis of …

Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection

SB Biering, SA Sarnik, E Wang, JR Zengel, SR Leist… - Nature …, 2022 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a range of
symptoms in infected individuals, from mild respiratory illness to acute respiratory distress …

The lactate and the lactate dehydrogenase in inflammatory diseases and major risk factors in COVID-19 patients

GS Gupta - Inflammation, 2022 - Springer
Lactate dehydrogenase (LDH) is a terminating enzyme in the metabolic pathway of
anaerobic glycolysis with end product of lactate from glucose. The lactate formation is crucial …

Age‐dependent and gender‐dependent antibody responses against SARS‐CoV‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA …

E Terpos, IP Trougakos, F Apostolakou… - American journal of …, 2021 - pmc.ncbi.nlm.nih.gov
To the Editor: Efficacy of vaccines against SARS-CoV-2 virus is of great importance to
mitigate the Covid-19 pandemic. 1 The BNT162b2 mRNA vaccine (Comirnaty) is the first …

[HTML][HTML] Long COVID-19 pathophysiology: what do we know so far?

NR Tziolos, P Ioannou, S Baliou, DP Kofteridis - Microorganisms, 2023 - mdpi.com
Long COVID-19 is a recognized entity that affects millions of people worldwide. Its broad
clinical symptoms include thrombotic events, brain fog, myocarditis, shortness of breath …

Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease

CA Labarrere, GS Kassab - Frontiers in Microbiology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus
disease 19 (COVID-19) has numerous risk factors leading to severe disease with high …

Metal complexes as antiviral agents for SARS‐CoV‐2

J Karges, SM Cohen - ChemBioChem, 2021 - Wiley Online Library
The severe acute respiratory syndrome–coronavirus 2 (SARS‐CoV‐2), the infectious agent
responsible for COVID‐19–has caused more than 2.5 million deaths worldwide and …

SARS‐CoV‐2 and dengue virus co‐infection: epidemiology, pathogenesis, diagnosis, treatment, and management

CNBS Prapty, R Rahmat, Y Araf… - Reviews in medical …, 2023 - Wiley Online Library
SARS‐CoV‐2 and dengue virus co‐infection cases have been on the rise in dengue‐
endemic regions as coronavirus disease 2019 (COVID‐19) spreads over the world, posing a …